
Seeing the molecular beauty of life
When Collins Maina was in secondary school in Kenya, a genetics class piqued his interest in science. He found especially fascinating how certain mutations can be disastrous to the well-being of organisms. And when he took his national exams, he was placed into a biochemistry program, which coincidentally turned out to be a good move for him.

from South Eastern Kenya University in November.
Maina attended South Eastern Kenya University, where he earned his bachelor’s degree in biochemistry and molecular biology in November. He said two particularly memorable classes were Biochemistry of Tumors and Biochemical Techniques and Instrumentation.
Not only were these classes interesting, he said, but he also was able to apply what he learned to his own life situation. Learning about the molecular and cellular bases of tumors helped him and his family when his grandfather developed prostate cancer.
“I remember I was the go-to guy for the family when they wanted to sort of analyze and translate the pathologist’s reports,” he said.
Learning about laboratory techniques in biochemistry was a highlight for Maina because of the physics involved. He was also able to carry and apply some of this knowledge to his career in industry as a medical representative.
In general, Maina said, biochemistry has helped him better understand what life is and how complex it is at the molecular level.
“It’s really fun knowing very well that beyond what you see in a person, you see there are a couple of three-letter sequences (codons) that determine who you are, determine the personality, determine so many things in your life — how a mishap in the placement of an amino acid, how a molecule that lacks the right conformation can have very detrimental effects on an organism,” he said. “At the basic level they are nothing more than molecules, very beautiful molecules.”
Maina values how relatable biochemistry is to real life. “If I don’t watch my health currently, I’m expecting to develop osteoporosis as I get into my 40s,” he said. “And so, it’s like reading the future.”
While applying to postgraduate programs and reading extensively about various areas of research, Maina has developed a passion for molecular microbiology and is particularly interested in quorum sensing, which involves responding to cell population density via gene regulation. He plans to continue his studies by earning a Master of Science degree, preferably in Canada, the United States, Scotland or New Zealand. He easily excelled in his undergraduate courses, but the high cost of and limited access to good schools make this goal quite difficult. Few research jobs are available in Kenya. Still, he remains hopeful.
Eventually, Maina said, he sees himself completing a Ph.D. program, doing a lot of research and retiring as a lecturer.
“I have so many questions I think I need to answer,” he said.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreFeatured jobs
from the ASBMB career center
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

In memoriam: Ralph G. Yount
He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.